medline.ch Respirationstrakt Neoplasie

	A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients. Transl Lung Cancer Res Girard N, Tan D, Cortinovis D, Lopes G, Voon PJ, Taylor MA, Ghali N, Zhan L, Xu S, Naicker K, Peters S. PMID: 41510396 [PubMed - in process]
	Real-world outcomes of trastuzumab deruxtecan as second- or further-line treatment in patients with HER2-mutant metastatic non-small cell lung cancer: a retrospective study. Transl Lung Cancer Res Huang K, Hu Z, Pan S, Qian J, Wu X, Wang H, Wang K, Lu H, Dong H, Chu T, Wang J. PMID: 41510395 [PubMed - in process]
	Clinical characteristics of post-operative N2 nodal upstaging in non-small cell lung cancer: a retrospective cohort study. Transl Lung Cancer Res Choi SY, Song MJ, Kwon BS, Kim YW, Park JS, Cho S, Lee JH, Lee CT, Lim SY. PMID: 41510389 [PubMed - in process]
	Development and validation of an interpretable machine learning model for prediction of occult lymph node metastasis in clinical stage T1 lung adenocarcinoma. Transl Lung Cancer Res Chen Y, Jin J, Mao Y, Zhou C, Zeng Q, Zhao J. PMID: 41510388 [PubMed]
	A study protocol of a single-arm, prospective, open-label, non-controlled, phase II study of neoadjuvant BL-B01D1 combined with aumolertinib in resectable stage II-IIIB non-small cell lung cancer patients with EGFR mutation. Transl Lung Cancer Res Chen Y, Mei J, Gao G, Zhang B, Li Y, Peng Z, Li C, Gan F, Pu Q, Liu C, Yang W, Liu L, Wang Y. PMID: 41510386 [PubMed]
	Exploring perioperative treatment for non-small cell lung cancer patients harboring EGFR mutation: a real-world multicenter cohort study. Transl Lung Cancer Res Zhou Y, Wei Z, Li M, Li J, Meng R, Wu F, Jiang G, Zhang B, Chen B, Zhou C, Jiang W, Zeng L, Wu L, Yan X, Pu X. PMID: 41510384 [PubMed - in process]
	Completion lobectomy following segmentectomy for malignant lung tumors: a multi-institutional study of surgical feasibility, oncologic outcomes, and diagnostic challenges (ESSG-02 study). Transl Lung Cancer Res Watanabe T, Fujino K, Sakane T, Handa Y, Doi T, Kawatani N, Nakazawa S, Iida T, Hanawa R, Shinohara S, Ito A, Tanahashi M. PMID: 41510383 [PubMed - in process]
	Development of a multimodal fully automated ensemble model to predict EGFR mutation and efficacy of EGFR-TKI in non-small cell lung cancer. Transl Lung Cancer Res Xu S, Miyawaki T, Shukuya T, Suzuki K, Shimamura SS, Matsuda H, Kanemaru R, Asao T, Mimori T, Otsuka Y, Takahashi K. PMID: 41510381 [PubMed - in process]
	Targeting ferroptosis to overcome drug resistance in lung cancer. Transl Lung Cancer Res Sheng P, Jin J, Liu H, Sun C, Chen Y, Chen X, Ma D, Shen J. PMID: 41510378 [PubMed - in process]
	The effects of neoadjuvant sintilimab versus pembrolizumab combined with chemotherapy on resectable non-small cell lung cancer: a multicenter propensity score-matched study. Transl Lung Cancer Res Sun Y, Gao Z, Luo Z, Tong L, Zhang Y, Dong X, Wang J, Li W, Li Z, Qiao W, Chen X, Duan H, Yan X. PMID: 41510377 [PubMed - in process]
	Computer-aided quantitative stromal analysis: a comprehensive investigation of its prognostic significance in lung squamous cell carcinoma. Transl Lung Cancer Res Zhang X, Chen J, Bu X, Huang Q, Li Y, Zhang D, Yang J, Feng A, Meng F, Li W, Sun Q, Xu C. PMID: 41510375 [PubMed - in process]
	Development and validation of machine learning models based on blood routine tests and tumor markers in early screening of primary bronchogenic lung cancer. Transl Lung Cancer Res Deng W, Pan L, Wang H, Liu Y, Peng X, Yang C, Li J, Han B. PMID: 41510374 [PubMed - in process]
	Diagnostic challenge of systemic amyloidosis mimicking EGFR-TKI toxicity in lung adenocarcinoma: a case report. Transl Lung Cancer Res Kim SY, Kang HS, Lee JE, Kim HY, Yeo MK, Chung C. PMID: 41510372 [PubMed - in process]
	Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscape. Transl Cancer Res Herrmann A, Grant C, Bazhenova L. PMID: 41510126 [PubMed - in process]
	An updated review on systemic therapy for brain metastases in non-small cell lung cancer. Transl Cancer Res Louis S, Aboubechara JP, Saigal K, Cao T, Nagpal S. PMID: 41510114 [PubMed - in process]
	Prognostic chromatin remodeling signature stratifies survival outcomes in lung adenocarcinoma patients. Transl Cancer Res Wang X, Liu Y, Huang D, Yuan M, Hong L. PMID: 41510075 [PubMed - in process]
	Development and validation of a circulating tumor DNA-based machine learning model for predicting immunotherapy response in non-small cell lung cancer. Transl Cancer Res Xia J, He T, Hu Y, Zhou D, Zou D, Li Y, Zhang M, Li B, Wang M, Liu X, Huang Z, Su S, Peng J. PMID: 41510072 [PubMed - in process]
	Human papillomavirus infection and its association with lung cancer: a case-control study (2011-2019). Iran J Microbiol Shakeri Z, Makvandi M, Mirzaei H, Kanani M, Jalilian S. PMID: 41510037 [PubMed - in process]
	Patient characteristics associated with death literacy in advanced non-small-cell lung cancer: A preliminary single-centre cross-sectional study. Palliat Care Soc Pract Lin GF, Yeh YL, Shun SC, Yang CY, Lin CP. PMID: 41509987 [PubMed]
	Advances in targeting KRAS mutations: A promising approach for the treatment of nonâ€‘small cell lung cancer (Review). Oncol Rep Sharma U, Song J, Kandu H, Zhu Y, Dai Z. PMID: 41508946 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 156332

Seite 1 von 7817



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung